This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0534U only for PROSTOX™ ultra from MiraDx Inc. This test analyzes 32 genetic variants, including microRNAs (small molecules that regulate gene expression) and single–nucleotide polymorphisms (SNPs), which are small changes in the DNA sequence. The test employs reverse transcription polymerase chain reaction (RT–PCR) to assess these variants and generates a risk score based on the findings. The risk score indicates the likelihood that the patient will develop genitourinary toxicity after radiation therapy, so the information helps guide clinicians in determining appropriate treatment strategies.
For clinical responsibility, terminology, tips and additional info
start codify free trial.